Perbak Capital Partners’s Alkermes ALKS Stock Holding History

Perbak Capital Partners’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-31,185	Closed	-$1.1M	–	16
2026 Q1	$1.1M	Buy	+31,185	New	+$967K	0.27%	37

Other funds holding ALKS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Perbak Capital Partners's ALKS Position: Q2 2026 in Review

Perbak Capital Partners sold out of Alkermes (ALKS) in Q2 2026, closing a stake of 31,185 shares — an estimated $1.1M sold.

Perbak Capital Partners first reported a position in ALKS in Q1 2026 and held it in 1 quarter. The position peaked at $1.1M in Q1 2026. 425 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

Perbak Capital Partners reported no remaining Alkermes position as of Q2 2026 after selling out during the quarter.
Perbak Capital Partners sold 31,185 Alkermes shares in Q2 2026, an estimated $1.1M.
Perbak Capital Partners first reported a position in Alkermes in Q1 2026 and held it in 1 quarter.
Perbak Capital Partners's Alkermes position peaked at $1.1M in Q1 2026.
425 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Perbak Capital Partners's 13F filing for Q2 2026.